Physician profile
Jordan Orr
NPI 1720499650
$2,075.28
in general payments reported to CMS, 2019-2025
11 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.96 · 2021: $1,312 · 2022: $282 · 2024: $318 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Summit Surgical Corp. | $1,200.00 | 2021 | |
| Boston Scientific Corporation | $352.05 | 2022-2025 | Axios, Wallflex Duodenal |
| Conmed Corporation | $154.74 | 2024 | Conmed Biliary |
| Medtronic, INC. | $111.60 | 2021 | |
| Evoke Pharma, INC. | $111.00 | 2022 | |
| Gilead Sciences, INC. | $46.92 | 2022 | |
| Merz Pharmaceuticals, LLC | $30.00 | 2022 | |
| Lundbeck LLC | $21.96 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.50 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.72 | 2022 | |
| Phathom Pharmaceuticals, INC. | $13.79 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Orr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.